Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Carroll

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1995
US case of the day. Gallstone ileusS L Summerton, A C Hollander, J Stassi, et al.
Genes and Immunity|June 20, 2008
Sex differences in the genetic architecture of susceptibility to Cryptococcus neoformans pulmonary infectionS F Carroll, J C Loredo Osti, L Guillot, et al.
The Journal of Biological Chemistry|August 15, 1992
Activity of recombinant mitogillin and mitogillin immunoconjugatesM Better, S L Bernhard, S P Lei, et al.
Journal of Clinical Pharmacology|December 1, 1999
Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal/permeability-increasing protein (rBPI21) in healthy volunteersR J Bauer, N Wedel, N Havrilla, et al.
Blood|January 1, 1991
Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrierD A Vallera, S F Carroll, D C Snover, et al.
Journal of Immunological Methods|January 3, 1994
Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISAM L White, J K Ma, C A Birr, et al.
Clinical and Experimental Immunology|April 1, 1996
Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disordersM P Stoffel, E Csernok, C Herzberg, et al.
Cancer Research|August 15, 1991
Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chainP W Trown, D T Reardan, S F Carroll, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1997
[Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases]A Schnabel, E Csernok, H Schultz, et al.
FEBS Letters|December 16, 1996
Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranesA B Schromm, K Brandenburg, E T Rietschel, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1995
US case of the day. Gallstone ileusS L Summerton, A C Hollander, J Stassi, et al.
Genes and Immunity|June 20, 2008
Sex differences in the genetic architecture of susceptibility to Cryptococcus neoformans pulmonary infectionS F Carroll, J C Loredo Osti, L Guillot, et al.
The Journal of Biological Chemistry|August 15, 1992
Activity of recombinant mitogillin and mitogillin immunoconjugatesM Better, S L Bernhard, S P Lei, et al.
Journal of Clinical Pharmacology|December 1, 1999
Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal/permeability-increasing protein (rBPI21) in healthy volunteersR J Bauer, N Wedel, N Havrilla, et al.
Blood|January 1, 1991
Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrierD A Vallera, S F Carroll, D C Snover, et al.
Journal of Immunological Methods|January 3, 1994
Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISAM L White, J K Ma, C A Birr, et al.
Clinical and Experimental Immunology|April 1, 1996
Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disordersM P Stoffel, E Csernok, C Herzberg, et al.
Cancer Research|August 15, 1991
Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chainP W Trown, D T Reardan, S F Carroll, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1997
[Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases]A Schnabel, E Csernok, H Schultz, et al.
FEBS Letters|December 16, 1996
Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranesA B Schromm, K Brandenburg, E T Rietschel, et al.
Pageof 7